Search by Drug Name or NDC
NDC 69547-0212-24 Narcan 2 mg/.1mL Details
Narcan 2 mg/.1mL
Narcan is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Emergent Devices Inc.. The primary component is NALOXONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Naloxone nasal spray is used along with emergency medical treatment to reverse the life-threatening effects of a known or suspected opiate (narcotic) overdose in adults and children. Naloxone nasal spray is in a class of medications called opiate antagonists. It works by blocking the effects of opiates to relieve dangerous symptoms caused by high levels of opiates in the blood.
Related Packages: 69547-0212-24Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Naloxone Nasal Spray
Product Information
| NDC | 69547-0212 |
|---|---|
| Product ID | 69547-212_1d0be895-cd43-49f3-98d4-72a9c3088616 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Narcan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | naloxone hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/.1mL |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Labeler Name | Emergent Devices Inc. |
| Pharmaceutical Class | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208411 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69547-0212-24 (69547021224)
| NDC Package Code | 69547-212-24 |
|---|---|
| Billing NDC | 69547021224 |
| Package | 24 VIAL, SINGLE-DOSE in 1 PACKAGE (69547-212-24) / .1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2017-01-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |